The thing that worries me a bit these days is the risk of extension of the PDUFA goal date. The FDA can still extend 2-3 months if Trimel has submitted a major amendment to the dossier. I hope that the TID / BID infight didn't result in Trimel submitting new data. Hopefully it's only a matter if altering the label etc. to reflect TID. Every day without an extension is a day gone well.